Clinical Scorecard: Management of Immune Complexes in Transplantation: Key Functions of Complement Factor H, Animal Studies, and Clinical Relevance

At a Glance

Key Highlights

• Immune complexes are dynamic regulators of graft injury.
• Complement factor H (CFH) modulates complement amplification and IC clearance.
• IC handling is a central determinant of transplant outcomes.
• Dysregulation of complement pathways predisposes to IC-mediated pathology.
• Emerging complement-targeted therapies may reshape transplant immunology.

Guideline-Based Recommendations

Diagnosis

• Monitor for donor-specific antibodies (DSA) as a marker of AMR.
• Assess complement activation markers in the context of ICs.

Management

• Implement immunosuppressive strategies targeting T cell activation.
• Consider complement-targeted therapies for managing AMR.

Monitoring & Follow-up

• Evaluate complement regulatory proteins and their role in IC handling.
• Regularly assess graft function and signs of microvascular inflammation.

Risks

• Risk of progressive graft loss due to antibody-driven rejection.
• Potential for dysregulated complement activation leading to tissue injury.

Patient & Prescribing Data

Patients with solid organ transplants at risk for AMR.

Focus on balancing immune surveillance with tissue preservation through effective IC handling.

Clinical Best Practices

• Integrate mechanistic insights into clinical observations for improved transplant outcomes.
• Utilize a systems-level understanding of IC formation and complement regulation.

Related Resources & Content

• Banff classification of AMR
• Role of complement in transplantation